JP2022543250A5 - - Google Patents

Info

Publication number
JP2022543250A5
JP2022543250A5 JP2022506745A JP2022506745A JP2022543250A5 JP 2022543250 A5 JP2022543250 A5 JP 2022543250A5 JP 2022506745 A JP2022506745 A JP 2022506745A JP 2022506745 A JP2022506745 A JP 2022506745A JP 2022543250 A5 JP2022543250 A5 JP 2022543250A5
Authority
JP
Japan
Prior art keywords
pyridine
fluorophenyl
oxo
carboxamide
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506745A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2020/010204 external-priority patent/WO2021025407A1/ko
Publication of JP2022543250A publication Critical patent/JP2022543250A/ja
Publication of JP2022543250A5 publication Critical patent/JP2022543250A5/ja
Pending legal-status Critical Current

Links

JP2022506745A 2019-08-02 2020-08-03 オキソ－ピリジン縮合環誘導体、およびそれを含む医薬組成物 Pending JP2022543250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190094455 2019-08-02
KR10-2019-0094455 2019-08-02
PCT/KR2020/010204 WO2021025407A1 (ko) 2019-08-02 2020-08-03 옥소-피리딘 융합고리 유도체 및 이를 포함하는 약학적 조성물

Publications (2)

Publication Number Publication Date
JP2022543250A JP2022543250A (ja) 2022-10-11
JP2022543250A5 true JP2022543250A5 (https=) 2023-08-10

Family

ID=74503219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506745A Pending JP2022543250A (ja) 2019-08-02 2020-08-03 オキソ－ピリジン縮合環誘導体、およびそれを含む医薬組成物

Country Status (6)

Country Link
US (1) US20220235064A1 (https=)
EP (1) EP4011885A4 (https=)
JP (1) JP2022543250A (https=)
KR (1) KR20210015730A (https=)
CN (1) CN114206883A (https=)
WO (1) WO2021025407A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023513675A (ja) * 2020-02-06 2023-04-03 ウェルマーカー・バイオ・カンパニー・リミテッド Ｋｒａｓ変異に関連する癌の予防または治療のための医薬組成物
KR20210111711A (ko) * 2020-03-03 2021-09-13 웰마커바이오 주식회사 Kras 돌연변이 및 활성화된 ron이 존재하는 암의 예방 또는 치료용 약학 조성물
JP2023526443A (ja) * 2020-05-18 2023-06-21 ウェルマーカー バイオ カンパニー リミテッド Ｒｏｎ変異が関与する非小細胞肺がんの予防又は治療用医薬組成物及びその使用方法
US20230202992A1 (en) * 2020-05-18 2023-06-29 Wellmarker Bio Co., Ltd. Pharmaceutical composition for preventing or treating small-cell lung cancer associated with ron mutants and method using same
KR20210142555A (ko) * 2020-05-18 2021-11-25 웰마커바이오 주식회사 Ron 돌연변이와 관련된 췌장암 예방 또는 치료용 약학 조성물 및 이를 이용한 방법
KR20220152155A (ko) * 2021-05-07 2022-11-15 웰마커바이오 주식회사 Ron 돌연변이와 관련된 담도암 예방 또는 치료용 약학 조성물
KR20220170766A (ko) * 2021-06-22 2022-12-30 주식회사 엘지화학 단백질 키나아제 억제제로서의 신규한 화합물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526761A (ja) * 2006-01-30 2009-07-23 アレイ バイオファーマ、インコーポレイテッド ヘテロ二環式チオフェン化合物および使用の方法
JP2009539878A (ja) * 2006-06-08 2009-11-19 アレイ バイオファーマ、インコーポレイテッド キノリン化合物および使用方法
SI2089364T1 (sl) * 2006-11-08 2013-10-30 Bristol-Myers Squibb Company Spojine piridinona
EP2423208A1 (en) * 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
JP2014513724A (ja) * 2011-05-16 2014-06-05 オーエスアイ・ファーマシューティカルズ，エルエルシー 融合二環キナーゼ阻害剤
CN102816175B (zh) * 2011-06-09 2015-12-16 上海汇伦生命科技有限公司 一种杂环并吡啶酮类化合物,其中间体、制备方法和用途
WO2013022519A1 (en) * 2011-08-10 2013-02-14 Merck Patent Gmbh Pyrido-pyrimidine derivatives
DK2820009T3 (en) 2012-03-01 2018-04-16 Array Biopharma Inc Serine / threonine kinase inhibitors
WO2014038881A2 (ko) * 2012-09-06 2014-03-13 씨제이제일제당 (주) 피리돈 유도체를 포함하는 단백질 키나제 억제제
CN103965107B (zh) * 2013-02-06 2016-08-17 沈阳药科大学 2-芳基取代喹啉类化合物及其用途
US20150299219A1 (en) * 2014-04-22 2015-10-22 Calitor Sciences, Llc Bicyclic pyrazolone compounds and methods of use
US11946934B2 (en) * 2014-09-03 2024-04-02 Wellmarker Bio Co., Ltd. Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereof
ES2749726T3 (es) * 2014-12-25 2020-03-23 Ono Pharmaceutical Co Derivado de quinolina
US11623923B2 (en) * 2017-11-24 2023-04-11 Medshine Discovery, Inc. Uracil compound as c-MET/AXL inhibitor
CN108314682A (zh) * 2018-01-31 2018-07-24 江西科技师范大学 6,7-双取代-4-芳杂喹啉类化合物的制备及应用
WO2019182274A1 (en) * 2018-03-08 2019-09-26 Wellmarker Bio Co., Ltd. Thienopyridine derivatives and pharmaceutical composition comprising same
CN109096250A (zh) * 2018-09-25 2018-12-28 辽宁大学 含哒嗪酮的4-苯氧基吡啶类化合物及其应用
KR20210111711A (ko) * 2020-03-03 2021-09-13 웰마커바이오 주식회사 Kras 돌연변이 및 활성화된 ron이 존재하는 암의 예방 또는 치료용 약학 조성물

Similar Documents

Publication Publication Date Title
JP2022543250A5 (https=)
KR101110530B1 (ko) 증식성 질환의 치료에 유용한 키나제 억제제
AU776077B2 (en) Use of CRF antagonists and related compositions
JP2024517695A (ja) 複素環式化合物及び使用方法
JP2025508702A (ja) キナゾリン化合物、及び変異ｋｒａｓタンパク質の阻害剤としてのその使用
JP2024532735A (ja) 複素環式化合物及び使用方法
JP2024517693A (ja) ２－アミノベンゾチアゾール化合物及びその使用方法
JP2024532733A (ja) 複素環式化合物及び使用方法
ES2620612T3 (es) Derivados de sulfóxidos y sulfonas de piridinilo y pirimidinilo
US20050209250A1 (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
JP2007522200A5 (https=)
JP2018529731A5 (https=)
JP2023549055A5 (https=)
WO2022093856A1 (en) Heterocyclic spiro compounds and methods of use
JP2016537384A5 (https=)
JP2019535664A5 (https=)
JP2020504136A5 (https=)
JP2020510092A5 (https=)
JP2013537210A5 (https=)
JP2015508075A5 (https=)
JP2020527174A5 (https=)
JP2009529047A5 (https=)
JP2022502490A5 (https=)
RU2013130907A (ru) Замещенные имидазохинолиновые производные
RU2012131115A (ru) Ингибиторы активности акт